학술논문

Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
Document Type
Article
Source
In Journal of the American Academy of Dermatology July 2021 85(1):71-78
Subject
Language
ISSN
0190-9622